|
Volumn 5, Issue 9, 2009, Pages 1317-1319
|
The 'RNA-binding ome': Future implications for chemotherapeutic efficacy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GEMCITABINE;
IMATINIB;
MESSENGER RNA;
MICRORNA;
TAMOXIFEN;
TRASTUZUMAB;
ANTINEOPLASTIC AGENT;
RNA;
RNA BINDING PROTEIN;
BREAST CANCER;
CANCER CELL;
CANCER CHEMOTHERAPY;
CANCER RESISTANCE;
CELL STRESS;
CHRONIC MYELOID LEUKEMIA;
DNA SEQUENCE;
DRUG CHOICE;
DRUG EFFICACY;
DRUG RESPONSE;
EDITORIAL;
GASTROINTESTINAL STROMAL TUMOR;
GENE EXPRESSION PROFILING;
GENE SEQUENCE;
HIGH THROUGHPUT SCREENING;
HUMAN;
PHARMACOGENETICS;
PREDICTION;
PRIORITY JOURNAL;
PROTEIN RNA BINDING;
RNA STABILITY;
RNA TRANSCRIPTION;
RNA TRANSLATION;
TRANSCRIPTION REGULATION;
ANIMAL;
GENETICS;
GENOME;
METABOLISM;
NEOPLASM;
ANIMALS;
ANTINEOPLASTIC AGENTS;
GENOME;
HUMANS;
NEOPLASMS;
RNA;
RNA-BINDING PROTEINS;
|
EID: 74949110667
PISSN: 14796694
EISSN: 17448301
Source Type: Journal
DOI: 10.2217/fon.09.114 Document Type: Editorial |
Times cited : (9)
|
References (7)
|